Sanofi_EFC18325_Phase 3 Anti-TL1A IBD Program - Ulcerative Colitis Pro00119361
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Sanofi US
Start Date
January 9, 2026
End Date
June 30, 2030
Administered By
Medicine, Gastroenterology
Awarded By
Sanofi US
Start Date
January 9, 2026
End Date
June 30, 2030